Current Concepts in Hematopathology 2022 ( VIDEOS)

Current Concepts in Hematopathology 2022 ( VIDEOS)

$50.00
$50.00
Sold out

[






Current Concepts in Hematopathology 2022 ( VIDEOS)



In this online CME program, leaders in diagnostic pathology deliver in-depth discussions of microscopic evaluation of hematolymphoid disorders, as well as the appropriate use of a broad range of ancillary studies. Current Concepts in Hematopathology delivers continuing medical education insights, including:



  • common pitfalls in the morphologic interpretation and immunophenotyping of hematolymphoid proliferations

  • approaches to cases that do not conform to WHO diagnostic categories

  • use of evidence-based guidelines, cytogenetics, and molecular testing to inform diagnosis


Learning Objectives


Upon completion of this activity, participants will be able to:



  • Correctly use morphologic criteria and cost-effectively use ancillary studies to diagnose a broad range of lymph node and bone marrow pathologies

  • Apply evidence-based criteria to the diagnosis of myeloid and lymphoid neoplasms

  • Diagnose challenging cases that do not readily conform to well-established entities

  • Evaluate and distinguish hematolymphoid malignancies from non-neoplastic mimics of malignancy


Target Audience


This course is targeted to specialty physicians who practice in pathology.


TOPICS / SPEAKERS




Nodal Small B-Cell Lymphomas – Elizabeth A. Morgan, MD


Plasma Cell Neoplasms and Lymphoplasmacytic Lymphoma – Valentina Nardi, MD


Question & Answer – Robert P. Hasserjian, MD – Moderator, Elizabeth A. Morgan, MD and Valentina Nardi, MD


Immunodeficiency and Viral-Associated Lymphoproliferations – Judith A. Ferry, MD


Updates in Cutaneous Lymphomas – Sam Sadigh, MD


Question & Answer – Elizabeth A. Morgan, MD – Moderator, Judith A. Ferry, MD and Sam Sadigh, MD


WHO Update – Follicular Lymphoma and Related Entities – Abner Louissaint Jr., MD, PhD


Diffuse Large B-Cell Lymphoma Subtypes – Scott B. Lovitch, MD, PhD


Question & Answer – Marian H. Harris, MD – Moderator, Abner Louissaint Jr, MD, PhD and Scott B. Lovitch, MD, PhD


Burkitt Lymphoma and High-Grade B-Cell Lymphomas – A Practical Guide and Update – Aliyah R. Sohani, MD


Reactive Lymphadenopathies and Castleman Disease – Yasodha Natkunam, MD, PhD


Question & Answer – Robert P. Hasserjian, MD – Moderator, Yasodha Natkunam, MD, PhD and Aliyah R. Sohani, MD


Approach to Peripheral Smear Review – Elizabeth Courville, MD


Myelodysplastic Syndrome and Its Differential Diagnosis – Robert P. Hasserjian, MD


Question & Answer – Elizabeth A. Morgan, MD – Moderator, Elizabeth Courville, MD and Robert P. Hasserjian, MD


Acute Myeloid Leukemia and Acute Leukemias of Ambiguous Lineage – Olga K. Weinberg, MD


Acute Lymphoblastic Leukemia – Marian H. Harris, MD, PhD


Question & Answer – Robert P. Hasserjian, MD – Moderator, Marian H. Harris, MD, PhD and Olga K. Weinberg, MD


Eosinophilia and Mastocytosis – Olga Pozdnyakova, MD, PhD


Myelodysplastic/Myeloproliferative Neoplasms – Robert P. Hasserjian, MD


Question & Answer – Marian H. Harris, MD, PhD – Moderator, Robert P. Hasserjian, MD and Olga Pozdnyakova, MD, PhD


Interpreting Flow Cytometry Minimal Residual Disease in Acute Leukemia – Sa A. Wang, MD


Practical Interpretation of Molecular Testing in Myeloid Neoplasms – Annette S. Kim, MD, PhD


Question & Answer – Elizabeth A. Morgan, MD – Moderator, Annette S. Kim, MD, PhD and Sa A. Wang, MD


Challenges in the Diagnosis of Hodgkin Lymphomas – Marian H. Harris, MD, PhD


Primary Mediastinal Large B-Cell and Grey-Zone Lymphomas – Scott J. Rodig, MD, PhD


Question & Answer – Robert P. Hasserjian, MD – Moderator, Marian H. Harris, MD, PhD and Scott J. Rodig, MD, PhD


Indolent T-Cell Disorders – Kathleen H. Burns, MD, PhD


Nodal T-Cell Lymphomas – Roberto Chiarle, MD


Question & Answer – Marian H. Harris, MD, PhD – Moderator, Kathleen H. Burns, MD, PhD and Roberto Chiarle, MD


Histiocytic and Dendritic Cell Neoplasms – Elizabeth A. Morgan, MD


IgG4-Related Disease and Lymphadenopathy – Jacob R. Bledsoe, MD


Blastic Plasmacytoid Dendritic Cell Neoplasm – Gabriel K. Griffin, MD


Question & Answer – Marian H. Harris, MD, PhD – Moderator, Jacob R. Bledsoe, MD, Gabriel K. Griffin, MD and Elizabeth A. Morgan, MD


Inherited Predisposition to Myeloid (and Hematological) Malignancies – Mark D. Fleming, MD, DPhil


Spleen Pathology – Lawrence R. Zukerberg, MD


Question & Answer – Elizabeth A. Morgan, MD – Moderator, Mark D. Fleming, MD, DPhil and Lawrence R. Zukerberg, MD


Date of Original Release: June 30, 2022


Termination Date: June 30, 2025














Reviews


There are no reviews yet.






Only logged in customers who have purchased this product may leave a review.








,





Current Concepts in Hematopathology 2022 ( VIDEOS)



In this online CME program, leaders in diagnostic pathology deliver in-depth discussions of microscopic evaluation of hematolymphoid disorders, as well as the appropriate use of a broad range of ancillary studies. Current Concepts in Hematopathology delivers continuing medical education insights, including:



  • common pitfalls in the morphologic interpretation and immunophenotyping of hematolymphoid proliferations

  • approaches to cases that do not conform to WHO diagnostic categories

  • use of evidence-based guidelines, cytogenetics, and molecular testing to inform diagnosis


Learning Objectives


Upon completion of this activity, participants will be able to:



  • Correctly use morphologic criteria and cost-effectively use ancillary studies to diagnose a broad range of lymph node and bone marrow pathologies

  • Apply evidence-based criteria to the diagnosis of myeloid and lymphoid neoplasms

  • Diagnose challenging cases that do not readily conform to well-established entities

  • Evaluate and distinguish hematolymphoid malignancies from non-neoplastic mimics of malignancy


Target Audience


This course is targeted to specialty physicians who practice in pathology.


TOPICS / SPEAKERS




Nodal Small B-Cell Lymphomas – Elizabeth A. Morgan, MD


Plasma Cell Neoplasms and Lymphoplasmacytic Lymphoma – Valentina Nardi, MD


Question & Answer – Robert P. Hasserjian, MD – Moderator, Elizabeth A. Morgan, MD and Valentina Nardi, MD


Immunodeficiency and Viral-Associated Lymphoproliferations – Judith A. Ferry, MD


Updates in Cutaneous Lymphomas – Sam Sadigh, MD


Question & Answer – Elizabeth A. Morgan, MD – Moderator, Judith A. Ferry, MD and Sam Sadigh, MD


WHO Update – Follicular Lymphoma and Related Entities – Abner Louissaint Jr., MD, PhD


Diffuse Large B-Cell Lymphoma Subtypes – Scott B. Lovitch, MD, PhD


Question & Answer – Marian H. Harris, MD – Moderator, Abner Louissaint Jr, MD, PhD and Scott B. Lovitch, MD, PhD


Burkitt Lymphoma and High-Grade B-Cell Lymphomas – A Practical Guide and Update – Aliyah R. Sohani, MD


Reactive Lymphadenopathies and Castleman Disease – Yasodha Natkunam, MD, PhD


Question & Answer – Robert P. Hasserjian, MD – Moderator, Yasodha Natkunam, MD, PhD and Aliyah R. Sohani, MD


Approach to Peripheral Smear Review – Elizabeth Courville, MD


Myelodysplastic Syndrome and Its Differential Diagnosis – Robert P. Hasserjian, MD


Question & Answer – Elizabeth A. Morgan, MD – Moderator, Elizabeth Courville, MD and Robert P. Hasserjian, MD


Acute Myeloid Leukemia and Acute Leukemias of Ambiguous Lineage – Olga K. Weinberg, MD


Acute Lymphoblastic Leukemia – Marian H. Harris, MD, PhD


Question & Answer – Robert P. Hasserjian, MD – Moderator, Marian H. Harris, MD, PhD and Olga K. Weinberg, MD


Eosinophilia and Mastocytosis – Olga Pozdnyakova, MD, PhD


Myelodysplastic/Myeloproliferative Neoplasms – Robert P. Hasserjian, MD


Question & Answer – Marian H. Harris, MD, PhD – Moderator, Robert P. Hasserjian, MD and Olga Pozdnyakova, MD, PhD


Interpreting Flow Cytometry Minimal Residual Disease in Acute Leukemia – Sa A. Wang, MD


Practical Interpretation of Molecular Testing in Myeloid Neoplasms – Annette S. Kim, MD, PhD


Question & Answer – Elizabeth A. Morgan, MD – Moderator, Annette S. Kim, MD, PhD and Sa A. Wang, MD


Challenges in the Diagnosis of Hodgkin Lymphomas – Marian H. Harris, MD, PhD


Primary Mediastinal Large B-Cell and Grey-Zone Lymphomas – Scott J. Rodig, MD, PhD


Question & Answer – Robert P. Hasserjian, MD – Moderator, Marian H. Harris, MD, PhD and Scott J. Rodig, MD, PhD


Indolent T-Cell Disorders – Kathleen H. Burns, MD, PhD


Nodal T-Cell Lymphomas – Roberto Chiarle, MD


Question & Answer – Marian H. Harris, MD, PhD – Moderator, Kathleen H. Burns, MD, PhD and Roberto Chiarle, MD


Histiocytic and Dendritic Cell Neoplasms – Elizabeth A. Morgan, MD


IgG4-Related Disease and Lymphadenopathy – Jacob R. Bledsoe, MD


Blastic Plasmacytoid Dendritic Cell Neoplasm – Gabriel K. Griffin, MD


Question & Answer – Marian H. Harris, MD, PhD – Moderator, Jacob R. Bledsoe, MD, Gabriel K. Griffin, MD and Elizabeth A. Morgan, MD


Inherited Predisposition to Myeloid (and Hematological) Malignancies – Mark D. Fleming, MD, DPhil


Spleen Pathology – Lawrence R. Zukerberg, MD


Question & Answer – Elizabeth A. Morgan, MD – Moderator, Mark D. Fleming, MD, DPhil and Lawrence R. Zukerberg, MD


Date of Original Release: June 30, 2022


Termination Date: June 30, 2025








]